Back to search

Article

Comprehensive Longitudinal ctDNA Monitoring in Metastatic Cancer Patients Treated with an Individualized Neoantigen-directed Vaccine

2024-12-07

Abstract excerpt

<h4>Purpose</h4> Circulating-tumor DNA (ctDNA) is an emerging, minimally invasive diagnostic and prognostic biomarker for patients receiving a variety of cancer therapies. Comprehensive and robust longitudinal monitoring of ctDNA can provide an understanding of tumor burden, heterogeneity, and response or resistance to treatment. <h4>Experimental Design</h4> ctDNA of 28 metastatic cancer patients receiving an in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
340f4a24-3810-5e2d-807a-b6e7f0769a3d
DOI
10.1101/2024.12.04.626817
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comprehensive Longitudinal ctDNA Monitoring in Metastatic Cancer Patients Treated with an Individualized Neoantigen-directed VaccineDOI 10.1101/2024.12.04.626817
Noninvasive MRD monitoring and profiling of clonal evolution by ctDNA in patients with advanced cancers treated within molecular tumor boardsSemantic proximity
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung CancerSemantic proximity
Multimodal ctDNA profiling for cancer detection and monitoring in pan-cancer patients with advanced disease enrolled in the SHIVA02 trialSemantic proximity
Identification and characterization of neoantigen-reactive CD8+ T cells following checkpoint blockade therapy in a pan-cancer settingSemantic proximity
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.Semantic proximity
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionSemantic proximity
Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.Semantic proximity
A digital PCR primer/probe library for physical tumor burden assessment through tumor-informed longitudinal ctDNA monitoringSemantic proximity
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors.Semantic proximity
Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR.Semantic proximity
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.Semantic proximity
Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis.Semantic proximity
Select a neighboring publication to make it the new centre.